STING1 and systemic lupus erythematosus: In autoimmune disorders (such as systemic lupus erythematosus) and inflammatory diseases, molecular markers of pathway dysregulation (e.g., circulating STING protein, IFN-associated cytokines) reflect disease activity, aiding diagnosis and treatment evaluation.